IGFBP2 and pachyonychia congenita: Another insulin-like growth factor-binding protein 2 (IGFBP2) was found to be associated with worse PC patients’ prognosis, by inducing the nuclear translocation and phosphorylation of the p65 subunit of nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) [66].